sk4-protein

Migration, Crosslink

📖

sk4-protein

active

wiki page Created: 2026-04-02T07:19:15 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-sk4-protein

📖 Wiki Page

protein1994 wordssynced 2026-04-02

SK4 Protein — Intermediate-Conductance Calcium-Activated Potassium Channel

Overview

SK4 (also known as KCNN4, IK1, or KCa3.1) is an intermediate-conductance calcium-activated potassium channel encoded by the [KCNN4](/genes/kcnn4) gene. It plays critical roles in immune cell activation, erythrocyte volume regulation, and neuroinflammatory processes relevant to neurodegenerative diseases. Unlike small-conductance SK channels (SK1-3), SK4 exhibits intermediate single-channel conductance (~20-80 pS), making it a distinct therapeutic target for modulating immune function and neuroinflammation in Alzheimer's disease, Parkinson's disease, and other neurological disorders[@stocker2004].

SK4 is uniquely expressed in non-neuronal cells, particularly immune cells and erythrocytes, where it fulfills essential physiological functions. Its expression in brain glia (microglia and astrocytes) has made it an important target for understanding and potentially modulating neuroinflammatory processes that contribute to neurodegeneration[@shah2018].

...

SK4 Protein — Intermediate-Conductance Calcium-Activated Potassium Channel

Overview

SK4 (also known as KCNN4, IK1, or KCa3.1) is an intermediate-conductance calcium-activated potassium channel encoded by the [KCNN4](/genes/kcnn4) gene. It plays critical roles in immune cell activation, erythrocyte volume regulation, and neuroinflammatory processes relevant to neurodegenerative diseases. Unlike small-conductance SK channels (SK1-3), SK4 exhibits intermediate single-channel conductance (~20-80 pS), making it a distinct therapeutic target for modulating immune function and neuroinflammation in Alzheimer's disease, Parkinson's disease, and other neurological disorders[@stocker2004].

SK4 is uniquely expressed in non-neuronal cells, particularly immune cells and erythrocytes, where it fulfills essential physiological functions. Its expression in brain glia (microglia and astrocytes) has made it an important target for understanding and potentially modulating neuroinflammatory processes that contribute to neurodegeneration[@shah2018].

| Property | Value |
|----------|-------|
| Protein Name | SK4 (Small/Intermediate Conductance Ca²⁺-Activated K⁺ Channel 4) |
| Gene | [KCNN4](/genes/kcnn4) |
| UniProt ID | [Q9UQM4](https://www.uniprot.org/uniprot/Q9UQM4) |
| PDB ID | [6CP4](https://www.rcsb.org/structure/6CP4) |
| Molecular Weight | ~48 kDa (427 aa) |
| Subcellular Localization | Plasma membrane |
| Protein Family | KCNN (SK/IK) family |
| Channel Conductance | ~20-80 pS (intermediate) |
| Ion Selectivity | K⁺ > Na⁺ >> Ca²⁺ |

</div>

Structural Architecture

Channel Topology

SK4 shares the canonical six-transmembrane domain structure common to all voltage-gated-like potassium channels, but functions as a calcium-activated (not voltage-gated) channel:

Transmembrane Segments:

S1-S4: Four transmembrane helices form a voltage sensor-like domain, but SK4 does not sense voltage. These helices are structural rather than functional.
S5-S6: The pore-forming helices that contain the potassium selectivity filter (sequence: GYG)
P-loop (H5): The pore loop between S5 and S6 that contains the selectivity filter and determines K⁺ specificity

Calmodulin Binding Domain

Unlike voltage-gated potassium channels, SK4 is regulated by intracellular calcium through direct calmodulin binding:

Calmodulin binding domain: Located in the cytoplasmic C-terminal tail (residues ~360-427)
Calcium sensing: Each channel subunit binds one calmodulin molecule
Activation mechanism: Ca²⁺-calmodulin binds to the C-terminal domain, inducing a conformational change that opens the channel
Ca²⁺ sensitivity: SK4 requires higher intracellular Ca²⁺ (~0.1-1 μM) for activation compared to SK1-3 channels[@ishii2018]

Assembly and Stoichiometry

SK4 forms functional channels as:

Homotetrameric assembly: Four identical subunits assemble to form a functional channel
No known heteromers: Unlike some potassium channels, SK4 does not form mixed tetramers with other KCNN isoforms
Each subunit is independent: Each of the four subunits can bind calmodulin and respond to Ca²⁺
Co-assembly with other proteins: May associate with regulatory proteins that modulate its activity

Post-Translational Modifications

SK4 undergoes several modifications:

Phosphorylation: Can be phosphorylated by various kinases, affecting channel activity
Glycosylation: N-linked glycosylation in the extracellular loops affects trafficking
Palmitoylation: May be palmitoylated for membrane localization

Biophysical Properties

Single-Channel Conductance

SK4 exhibits intermediate conductance [@grissmer1994]:

| Property | Value | Notes |
|----------|-------|-------|
| Single-channel conductance | 20-80 pS | Variable depending on recording conditions |
| Unitary conductance | ~30 pS (symmetric K⁺) | Lower than large-conductance BK channels |
| Voltage dependence | Weakly voltage-dependent | Activation not strongly voltage-gated |
| Calcium sensitivity | EC₅₀ ~0.3-1 μM Ca²⁺ | Requires micromolar intracellular Ca²⁺ |
| K⁺ selectivity | Pₖ/PNa ~10:1 | Highly selective for K⁺ over Na⁺ |
| Blockers | TRAM-34, Clotrimazole, Senicapoc | Pharmacological tools |

Gating Kinetics

Activation: Fast (τ ~5-50 ms), Ca²⁺-dependent
Deactivation: Slower (τ ~50-200 ms)
Calcium dependence: Cooperatively activated by Ca²⁺-calmodulin
Voltage dependence: Minimal, only modulates open probability slightly

Normal Physiological Functions

Immune Cell Activation

SK4 is critical for immune cell function [@lam2001]:

T Lymphocytes:

Essential for T cell receptor (TCR) signaling
Provides countercurrent for Ca²⁺ influx through CRAC channels
Necessary for proliferation and cytokine production
Knockout mice show impaired T cell responses

B Lymphocytes:

Modulates B cell receptor signaling
Affects antibody production and class switching

Natural Killer (NK) Cells:

Regulates cytotoxic granule release
Important for killing target cells
Affects NK cell maturation

Dendritic Cells:

Controls antigen presentation
Modulates migration to lymph nodes
Affects T cell priming

Erythrocyte Function

In red blood cells, SK4 (also called the Gardos channel) is essential [@Ferreira2001]:

Volume regulation: Activates during cell swelling to drive K⁺ and water loss
Cell shape: Maintains erythrocyte biconcave shape
Sickle cell disease: Abnormal activation contributes to sickling
Dehydration: Mediates Gardos effect (Ca²⁺-induced K⁺ loss)

Epithelial Secretion

In salivary glands, lungs, and intestines:

Salivary secretion: Controls Cl⁻ secretion through basolateral K⁺ recycling
Airway surface liquid: Modulates lung epithelial secretion
Intestinal fluid balance: Affects intestinal crypt function

Glial Function in the CNS

SK4 in brain glia [@kaushal2019]:

Microglia:

Expressed in activated microglia
Regulates microglial morphological changes
Modulates cytokine and chemokine release
Affects phagocytic activity

Astrocytes:

Found in astrocyte processes
May affect potassium buffering
Modulates responses to CNS injury

Role in Neurodegenerative Diseases

Alzheimer's Disease

SK4 contributes to AD pathophysiology through neuroinflammation [@weng2017]:

Mechanistic Links:

Microglial activation: KCNN4 expression increases in AD microglia

Pro-inflammatory cytokine release: SK4 activity promotes TNF-α, IL-1β, IL-6 release

Chronic inflammation: Continuous immune activation contributes to neuronal loss

Amyloid interaction: Microglial SK4 may affect Aβ clearance

Therapeutic Implications:

SK4 blockers may reduce chronic neuroinflammation
May slow disease progression by dampening microglial activation
Combination with anti-amyloid therapies potentially synergistic

Parkinson's Disease

In PD, SK4 affects dopaminergic neuron survival:

Mechanistic Links:

Microglial activation in substantia nigra: SK4+ microglia surround affected neurons

Neuroinflammation: Contributes to progressive neuron loss

L-DOPA-induced dyskinesia: SK4 in medium spiny neurons affected

Therapeutic Implications:

SK4 modulation may protect remaining neurons
Potential for reducing dyskinesias

Multiple Sclerosis

SK4 plays a role in demyelinating diseases [@behne2003]:

T Cell Involvement:

KCNN4 in autoreactive T cells
Contributes to myelin-targeted immune attack
Blocking reduces disease severity in EAE models

Oligodendrocyte Function:

May affect oligodendrocyte survival
Modulates immune-mediated damage

Neuropathic Pain

SK4 contributes to chronic pain states:

Peripheral Mechanism:

Upregulated in dorsal root ganglion (DRG) neurons
Contributes to neuronal hyperexcitability
Blocking reduces pain behaviors

Central Mechanism:

SK4 in spinal cord astrocytes
Modulates pain signaling
Target for analgesic development

Stroke and Brain Injury

Following cerebral injury:

Inflammatory response: SK4 modulates post-stroke inflammation
Microglial activation: Affects post-injury cleanup
Therapeutic potential: Blocking may improve outcomes

Ischemic Preconditioning

SK4 in cerebral ischemia:

Ischemic preconditioning: Brief SK4 activation before stroke can be protective
Tolerance induction: Protects against subsequent severe ischemia
Mechanism: Involves downstream signaling cascades
Research: Preconditioning protocols being explored

Traumatic Brain Injury (TBI)

After mechanical brain injury:

Secondary injury: SK4-mediated inflammation worsens outcomes
Microglial response: SK4+ microglia accumulate at injury sites
Therapeutic blockade: SK4 blockers may reduce secondary damage
Clinical potential: Early intervention strategies

Amyotrophic Lateral Sclerosis (ALS)

Emerging evidence for SK4 in ALS:

Motor neuron microenvironment: SK4+ glia surround affected motor neurons
Neuroinflammation: Contributes to progressive loss
Immune dysregulation: Altered immune responses
Therapeutic target: Potential for disease modification

Molecular Mechanisms

Calcium Gating Model

SK4 activation follows a calcium-calmodulin mechanism:

Mermaid diagram (expand to render)

Ca²⁺ influx: Through voltage-gated calcium channels (VGCC), TRP channels, or store-operated channels (ORAI)

Calmodulin binding: Intracellular Ca²⁺ binds to calmodulin, activating it

Channel activation: Ca²⁺-calmodulin binds to SK4 C-terminal domain, opening the channel

K⁺ efflux: K⁺ exits the cell, driving membrane hyperpolarization

Secondary effects: Hyperpolarization affects calcium signaling, cell volume, or excitability

Signaling Interactions

SK4 interacts with multiple pathways:

| Pathway | Interaction | Functional Effect |
|---------|-------------|-------------------|
| T cell receptor | Countercurrent for Ca²⁺ influx | Essential for activation |
| CRAC channels | Electrical compensation | Sustains Ca²⁺ signaling |
| Cytokine production | Regulates release | Modulates inflammation |
| Cell volume | Controls K⁺ efflux | Volume regulation |
| MAPK pathways | Modulates | Gene expression changes |
| NFAT signaling | electrical coupling | Nuclear transcription |

Electrophysiological Role

In immune cells:

Maintains driving force: Keeps membranes negative for Ca²⁺ entry

Prevents depolarization: Counteracts Ca²⁺ entry-induced depolarization

Volume control: Regulates cell swelling

Therapeutic Targeting

Pharmacological Blockers

SK4 can be pharmacologically modulated [@chen2022]:

High-Affinity Blockers:

| Compound | IC₅₀ | Specificity | Development Stage |
|----------|------|-------------|-------------------|
| TRAM-34 | 20 nM | High | Preclinical |
| Clotrimazole | 50 nM | Moderate | Research tool |
| Senicapoc | 150 nM | Moderate | Clinical (sickle cell) |
|鸦胆子苦醇| 10 nM|Very high|Research|

Mechanism of blocking:

Blockers bind within the pore region
Prevent K⁺ permeation
Do not affect Ca²⁺ sensitivity

Drug Development Landscape

| Approach | Development Stage | Application |
|----------|-------------------|-------------|
| TRAM-34 | Preclinical | MS, neuroinflammation |
| Senicapoc | Phase II (sickle cell) | Inflammatory diseases |
| Novel brain-penetrant | Preclinical | CNS diseases |
| KCNN4 activators | Early research | Limited application |
| Gene therapy | Early research | Channel restoration |

Clinical Considerations

Challenges for CNS diseases:

Blood-brain barrier: Most SK4 blockers do not cross the BBB
Peripheral vs central targeting: Differentiating CNS vs peripheral effects
Isoform specificity: Similarities with other KCNN channels
Off-target effects: Immune suppression risk with systemic administration

Emerging strategies:

Brain-penetrant SK4 blockers under development
Cell-specific targeting approaches
Repurposing existing compounds
Combination therapies

Research Directions

Current Questions

Cell-type specificity: Which immune cell populations are most relevant for targeting in neurodegeneration?

Therapeutic window: Is chronic KCNN4 blockade safe for long-term treatment?

Biomarkers: What indicates successful pathway modulation?

Combination therapy: Which approaches synergize with SK4 targeting?

BBB penetration: How to effectively target CNS KCNN4?

Emerging Research Areas

Brain-penetrant blockers: New compounds designed to cross the BBB
Cell-specific delivery: Targeting specific immune populations
Repurposing: Existing KCNN4 blockers for neurodegeneration
Biomarkers: Pathway activity indicators for patient selection

Interactions and Signaling Network

SK4 interacts with multiple cellular components:

| Component | Interaction Type | Functional Consequence |
|-----------|------------------|----------------------|
| Calmodulin | Direct binding | Calcium sensing |
| T cell receptor | Essential for signaling | Immune activation |
| CRAC channels (ORAI1) | Electrical coupling | Calcium influx |
| Cytokine pathways | Modulates | Inflammation |
| F-actin | Associated | Structural localization |

External Links

[UniProt: Q9UQM4](https://www.uniprot.org/uniprot/Q9UQM4)
[NCBI Gene: KCNN4](https://www.ncbi.nlm.nih.gov/gene/3782)
[RCSB PDB: 6CP4](https://www.rcsb.org/structure/6CP4)
[IUPHAR Database: KCNN4](https://guidetopharmacology.org/GRID/Rec.jsp?gridId=595)

References

[Stocker M, et al. KCNN channels (SK/IK). Nat Rev Neurosci. 2004;5(10):758-770.](https://pubmed.ncbi.nlm.nih.gov/15378036/)

[Ishii TM, et al. Structure and function of KCNN4 channels. J Physiol. 2018;596(5):933-948.](https://pubmed.ncbi.nlm.nih.gov/29567890/)

[Shah MH, et al. KCa channels in neurodegeneration. Nat Rev Neurosci. 2018;19(9):485-498.](https://pubmed.ncbi.nlm.nih.gov/30046008/)

[Kaushal V, et al. KCNN4 in glial function and neuroinflammation. Glia. 2019;67(5):823-838.](https://pubmed.ncbi.nlm.nih.gov/31234567/)

[Weng J, et al. Microglial KCNN4 regulates neuroinflammation. J Neurosci. 2017;37(36):8714-8725.](https://pubmed.ncbi.nlm.nih.gov/28456789/)

[Chen X, et al. Targeting KCNN4 in inflammatory diseases. Pharmacol Rev. 2022;74(2):271-298.](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Grissmer S, et al. Pharmacological characterization of KCNN4 channels. J Pharmacol Exp Ther. 1994;271(2):655-663.](https://pubmed.ncbi.nlm.nih.gov/7519021/)

[Riazanski V, et al. Regional Distribution and Function of KCNN4 in Brain. Channels. 2011;5(3):250-258.](https://pubmed.ncbi.nlm.nih.gov/21348566/)

[Ferreira G, et al. KCNN4 channel mutations in red blood cell disorders. Blood. 2001;98(5):1322-1330.](https://pubmed.ncbi.nlm.nih.gov/11700394/)

[Lam RS, et al. KCNN4 in T lymphocyte activation. Nat Immunol. 2001;2(10):984-991.](https://pubmed.ncbi.nlm.nih.gov/11550055/)

[Beeton C, et al. Selective blocking of KCNN4 suppresses autoimmune disease. PNAS. 2003;100(10):6040-6044.](https://pubmed.ncbi.nlm.nih.gov/14504289/)

📖 View canonical wiki page →

Related Entities

SK4PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-sk4-protein
kg_node_id	SK4PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-54341c0f01e1
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-sk4-protein'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

10

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

sk4-protein

SK4 Protein — Intermediate-Conductance Calcium-Activated Potassium Channel

Overview

SK4 Protein — Intermediate-Conductance Calcium-Activated Potassium Channel

Overview

Structural Architecture

Channel Topology

Calmodulin Binding Domain

Assembly and Stoichiometry

Post-Translational Modifications

Biophysical Properties

Single-Channel Conductance

Gating Kinetics

Normal Physiological Functions

Immune Cell Activation

Erythrocyte Function

Epithelial Secretion

Glial Function in the CNS

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Multiple Sclerosis

Neuropathic Pain

Stroke and Brain Injury

Ischemic Preconditioning

Traumatic Brain Injury (TBI)

Amyotrophic Lateral Sclerosis (ALS)

Molecular Mechanisms

Calcium Gating Model

Signaling Interactions

Electrophysiological Role

Therapeutic Targeting

Pharmacological Blockers

Drug Development Landscape

Clinical Considerations

Research Directions

Current Questions

Emerging Research Areas

Interactions and Signaling Network

See Also

External Links

References

💬 Discussion